AIT Austrian Institute of Technology GmbH:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:AIT Austrian Institute of Technology GmbH - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10317
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストリア
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
AIT Austrian Institute of Technology GmbH (AIT) is a research and technology organisation which provides research and development services. The institute provides research and technological development for infrastructure related technologies in the fields of energy, mobility systems, low-emission transport, health and bioresources, digital safety and security, automation and control, among others. Its health and environment research services include biomedical and bio molecular solutions, biological resources database, microbial detection and water treatment, among others. It offers services for the preparation of smart grids, photovoltaics, thermal energy systems, smart cities and develops business models in mobility, and digital safety and security. It operates in Vienna, Wiener Neustadt, Braunau am Inn, Graz, Tirol and Tulln, Austria. AIT is headquartered in Vienna, Austria.

AIT Austrian Institute of Technology GmbH – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
AIT Austrian Institute of Technology GmbH, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
AIT Austrian Institute of Technology GmbH, Medical Equipment Deals By Type, 2012 to YTD 2018 6
AIT Austrian Institute of Technology GmbH, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
AIT Austrian Institute of Technology GmbH, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
AIT Austrian Institute of Technology GmbH, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
AIT Austrian Institute of Technology GmbH, Medical Equipment, Deal Details 10
Partnerships 10
Blue Earth Diagnostics and Seibersdorf Lab Enters into Distribution Agreement 10
Nanyang Technological University Enters into Research Agreement with Austrian Institute of Technology and Medical University of Vienna 11
Caprion Biosciences, Asuragen and AIT Austrian Institute of Technology Enter into Agreement with Cancer Research and Abcodia 12
AIT Austrian Institute Enters into Co-Development Agreement with BioVendor and Scienion 14
RiboMed Enters Into Development Agreement With Austrian Institute Of Technology For Lung Cancer Assay 15
Abcodia Partners with AIT Austrian Institute of Technology 16
AIT Austrian Institute of Technology GmbH – Key Employees 17
AIT Austrian Institute of Technology GmbH – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
AIT Austrian Institute of Technology GmbH, Medical Equipment, Key Facts 2
AIT Austrian Institute of Technology GmbH, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
AIT Austrian Institute of Technology GmbH, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
AIT Austrian Institute of Technology GmbH, Medical Equipment Deals By Type, 2012 to YTD 2018 6
AIT Austrian Institute of Technology GmbH, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
AIT Austrian Institute of Technology GmbH, Deals By Market, 2012 to YTD 2018 8
AIT Austrian Institute of Technology GmbH, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Blue Earth Diagnostics and Seibersdorf Lab Enters into Distribution Agreement 10
Nanyang Technological University Enters into Research Agreement with Austrian Institute of Technology and Medical University of Vienna 11
Caprion Biosciences, Asuragen and AIT Austrian Institute of Technology Enter into Agreement with Cancer Research and Abcodia 12
AIT Austrian Institute Enters into Co-Development Agreement with BioVendor and Scienion 14
RiboMed Enters Into Development Agreement With Austrian Institute Of Technology For Lung Cancer Assay 15
Abcodia Partners with AIT Austrian Institute of Technology 16
AIT Austrian Institute of Technology GmbH, Key Employees 17
AIT Austrian Institute of Technology GmbH, Other Locations 19
AIT Austrian Institute of Technology GmbH, Subsidiaries 19

List of Figures
AIT Austrian Institute of Technology GmbH, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
AIT Austrian Institute of Technology GmbH, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
AIT Austrian Institute of Technology GmbH, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
AIT Austrian Institute of Technology GmbH, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
AIT Austrian Institute of Technology GmbH, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
AIT Austrian Institute of Technology GmbH, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
AIT Austrian Institute of Technology GmbH, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
AIT Austrian Institute of Technology GmbH, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[AIT Austrian Institute of Technology GmbH:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ATCO Power Ltd:企業の戦略的SWOT分析
    ATCO Power Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Chemical Company of Malaysia Berhad (CCM)-製薬・医療分野:企業M&A・提携分析
    Summary Chemical Company of Malaysia Berhad (CCM) is an industrial and specialty chemicals company. Its core business activities include provision of pharmaceuticals and healthcare products; chemical products and applications; and polymer coatings and applications. The company’s product range find a …
  • Bristol-Myers Squibb Co (BMY)-製薬・医療分野:企業M&A・提携分析
    Summary Bristol-Myers Squibb Company (BMS) is specialty biopharmaceutical company that carries out the discovery, development, licensing, manufacturing, marketing, distribution and sale of medicines to patients with serious diseases. Its primary focus is in cancer, cardiovascular, immunoscience and …
  • The Hong Kong and China Gas Company Limited:企業の戦略・SWOT・財務分析
    The Hong Kong and China Gas Company Limited - Strategy, SWOT and Corporate Finance Report Summary The Hong Kong and China Gas Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Aurora Spine Corp (ASG):医療機器:M&Aディール及び事業提携情報
    Summary Aurora Spine Corp (Aurora) is a medical equipment provider that offers surgical tools. The company offers novel solutions in the spinal implant market through a range of minimally invasive, and regenerative spinal implant technologies. It develops and distributes spinal implant products whic …
  • Actinogen Medical Ltd (ACW):企業の財務・戦略的SWOT分析
    Summary Actinogen Medical Ltd (Actinogen), formerly Actinogen Ltd is a biotechnology company that develops novel treatments for alzheimer’s disease and the cognitive decline associated with neurodegenerative diseases and metabolic diseases. The company’s xanamem is a novel drug under development for …
  • Interleukin Genetics Inc (ILIU)-製薬・医療分野:企業M&A・提携分析
    Summary Interleukin Genetics Inc (Interleukin) is a molecular diagnostics company which develops and distributes genetic tests for the personalized health market. Its major genetic tests include ILUSTRA genetic risk test ; cardiovascular risk test; weight management genetic test; bone health genetic …
  • Lin Bioscience Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Lin Bioscience Inc (Lin Bioscience) is a drug development company that specializes in developing therapies for oncology, ophthalmology and other metabolic diseases. The company’s pipeline product LBS-008 is an oral therapy for treatment of macular degeneration; LBS-007 is a small molecular i …
  • BankAxept AS:企業の戦略・SWOT・財務情報
    BankAxept AS - Strategy, SWOT and Corporate Finance Report Summary BankAxept AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Brookfield Property REIT Inc (BPYU):企業の財務・戦略的SWOT分析
    Brookfield Property REIT Inc (BPYU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Manipal Hospital:製薬・医療:M&Aディール及び事業提携情報
    Summary Manipal Hospital, formerly Manipal Health Systems is a healthcare service provider that offers primary, secondary and tertiary healthcare services. The hospital offers services such as robotic assisted surgery, eye care, rehabilitation, skin care, accident and emergency care, child care, den …
  • BW Group Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary BW Group Ltd (BW Group) formerly Bergesen Worldwide Limited, is an oil and gas company which provides maritime services. The company offers oil and gas shipping and others related services. It offers environmental technologies, floating gas infrastructure, and deepwater production services. …
  • California Resources Corp (CRC):石油・ガス:M&Aディール及び事業提携情報
    Summary California Resources Corp (CRC) is an oil and gas company that explores for, produces, processes, gathers, and markets crude oil, natural gas and natural gas liquids. It has conventional and unconventional assets across major oil and gas basins such as San Joaquin, Los Angeles, Ventura and S …
  • Eaton Vance Corp:企業の戦略・SWOT・財務分析
    Eaton Vance Corp - Strategy, SWOT and Corporate Finance Report Summary Eaton Vance Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Bharat Sanchar Nigam Ltd:企業の戦略的SWOT分析
    Bharat Sanchar Nigam Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Talwalkars Better Value Fitness Ltd (TALWALKARS):企業の財務・戦略的SWOT分析
    Talwalkars Better Value Fitness Ltd (TALWALKARS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key s …
  • Minesto AB (MINEST):電力:M&Aディール及び事業提携情報
    Summary Minesto AB (Minesto) is a marine energy technology developer. The company offers ervices such as renewable energy solutions, tidal power plants operations and management, power generation, and deep green technology solutions. It also provides control-system design, hydrodynamics, simulation, …
  • Asn Bank
    Asn Bank - Strategy, SWOT and Corporate Finance Report Summary Asn Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Osprey Medical Inc (OSP):医療機器:M&Aディール及び事業提携情報
    Summary Osprey Medical Inc (Osprey Medical) is a medical device company that designs, develops, and manufacturers proprietary devices and monitoring systems. The company offers contrast removal system, which is designed to provide cardiologists with an advanced level of CIN protection in high risk p …
  • Ardena Holding NV:製薬・医療:M&Aディール及び事業提携情報
    Summary Ardena Holding NV (Ardena) is a contract development and manufacturing organization. The company offers solid-state chemistry services including polymorph, salt, and co-crystal screening; bio-analytical and formulation development; early-phase clinical supply manufacturing; clinical logistic …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆